SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRotork Regulatory News (ROR)

Share Price Information for Rotork (ROR)

Share Price is delayed by 15 minutes
Get Live Data
305.60    2.00 (0.66%)
Bid:
305.40
Ask:
306.00
Spread: 0.60 (0.196%)
Market Cap: £2.49b
ROR Live PriceLast checked at - London Stock Exchange

Intraday Rotork Share Chart

Trading Update

13 Nov 2015 07:00

RNS Number : 5799F
Rotork PLC
13 November 2015
Β 

13 November 2015

Rotork plc

Trading Update

Rotork p.l.c ("Rotork"), the market leading actuator manufacturer and flow control company, issues the following trading update covering the period from 1 July to 12 November 2015.

The trading environment has remained challenging across most of our key markets and geographies; however our expectations for the full year remain unchanged from the guidance issued on 17 September 2015.

Quotation activity in the third quarter was similar to the prior year but order intake was 17.2% lower (-17.3% OCC). Cumulative order intake in the ten months to 25 October was 12.5% lower (-15.1% OCC) than the same period in 2014. Revenue for the third quarter was 18.1% lower (-18.6% OCC) than the comparable period with cumulative revenue 7.1% lower (-10.0% OCC) than the prior year. The order book at 25 October was Β£185m, a 13.3% reduction (-13.1% OCC) compared with the same point last year.

Although our quote activity has remained encouraging, the timing of order placement and product delivery remains difficult to forecast.

We continue to implement our previously announced cost management initiatives and we are on track to achieve the savings indicated at the time of our half year results.

Today we are announcing the small acquisition of Eltav which provides wireless technology for the valve industry and will strengthen our wireless offering.

Rotork Controls

Order intake in the third quarter was down 17.5% (-15.9% OCC) on the same period last year. Cumulative order intake was down 13.3% (-13.2% OCC) on the prior year. The oil and gas market continues to be impacted by reduced levels of activity, with projects moving slowly or being postponed into next year. There are positive signs in power related markets, with recent project approvals supportive of our expectation of improved activity in 2016. We continue to expand our end market exposure as we look for areas of increased activity. Our products are often mission critical and this supports our after-market business which continues to see good levels of growth.

Rotork Fluid Systems

Trading in the period continued to be very challenging with order intake in the third quarter down 26.9% (-26.0% OCC) on the same period last year. Project deferrals and cancellations due to oil companies reassessing the feasibility of planned capital projects continue to impact all geographic regions of the business. We are planning for an extended period of weakness but see opportunities in areas where investment is still required, such as safety and cost reduction initiatives by our customers. Our global sales network continues to play an important part in winning projects and providing local support.

Rotork Gears

Third quarter order intake was down 4.2% (+0.1 OCC). Cumulative order intake was down 3.0% (-1.3% OCC). All regions are performing at similar levels to the prior year with the exception of Asia, reflecting the weakness in the oil and gas market and the difficult trading environment in China. The integration of Roto Hammer, acquired in September, is progressing well.

Rotork Instruments

The Instruments division continues to grow by acquisition and organically. Order intake in the third quarter was 7.0% higher (-12.5% OCC). Cumulative order intake was up 37.8% (-8.9% OCC) on the prior year. The division's results for the third quarter include first-time contributions from M&M, acquired on 3 August, and Bifold, acquired on 27 August. Good progress is being made on the integration of both companies. Central to the strategy of this division is to increase the geographical spread of the business and progress is being made in this regard.

Financial position

The Group continues to be highly cash generative and maintains a strong balance sheet with a high return on capital employed. Net debt at 25 October was Β£86m.

Outlook

Our expectations for the full year remain unchanged from our guidance of 17 September 2015 that, based on current exchange rates, revenue for the year will be in the range of Β£530-Β£555m with adjusted operating profit in the range of Β£120m-Β£130m.

For further information, please contact:

Β 

Β 

Β 

Rotork p.l.c.

Tel: 01225 733200

Peter France, Chief Executive

Β 

Jonathan Davis, Finance Director

Β 

Β 

Β 

FTI Consulting

Tel: 020 3727 1340

Nick Hasell / Susanne Yule

Β 

Β 

Notes

1. 2015 figures quoted are at actual exchange rates and 2014 are as previously reported.

2. OCC (organic constant currency) growth rates remove the results of the businesses acquired during 2014 and 2015 that were not consistently in both periods' results and restate 2015 at 2014 exchange rates.

3. Third quarter results refer to the period from 1 July to 27 September 2015. Cumulative results refer to the period from 1 January to 25 October 2015.

4. Rotork will be announcing its results for the period ending 31 December 2015 on 1 March 2016.

5. This announcement contains certain forward-looking statements with respect to the operations, performance and financial condition of the Group. By their nature, these statements involve uncertainty since future events and circumstances can cause results and developments to differ materially from those anticipated. The forward-looking statements reflect knowledge and information available at the date of preparation of this announcement and Rotork undertakes no obligation to update these forward-looking statements.Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTLLFIDLTLFLIE
Date   Source Headline
1st Feb 20234:00 pmRNSTotal Voting Rights
11th Jan 20234:00 pmRNSDirector/PDMR Shareholding
3rd Jan 202311:30 amRNSTotal Voting Rights
13th Dec 20224:00 pmRNSDirector/PDMR Shareholding
1st Dec 20222:00 pmRNSTotal Voting Rights
1st Dec 20227:00 amRNSAppointment of Chair Designate
25th Nov 20223:00 pmRNSHolding(s) in Company
23rd Nov 20227:00 amRNSTrading Update
17th Nov 20223:30 pmRNSHolding(s) in Company
16th Nov 20223:30 pmRNSHolding(s) in Company
11th Nov 20223:00 pmRNSDirector/PDMR Shareholding
4th Nov 20225:15 pmRNSHolding(s) in Company
3rd Nov 202211:00 amRNSHolding(s) in Company
2nd Nov 20227:00 amRNSCapital Markets Event
1st Nov 20223:30 pmRNSHolding(s) in Company
1st Nov 202211:00 amRNSTotal Voting Rights
31st Oct 20223:30 pmRNSHolding(s) in Company
28th Oct 20223:00 pmRNSHolding(s) in Company
25th Oct 20229:00 amRNSNear-term emissions targets approved by SBTi
17th Oct 20223:00 pmRNSHolding(s) in Company
13th Oct 20224:30 pmRNSHolding(s) in Company
13th Oct 20223:00 pmRNSHolding(s) in Company
12th Oct 20224:00 pmRNSDirector/PDMR Shareholding
12th Oct 20223:00 pmRNSHolding(s) in Company
11th Oct 20224:00 pmRNSDirector/PDMR Shareholding
5th Oct 20229:30 amRNS2022 AGM Voting Outcome Update Statement
3rd Oct 20225:45 pmRNSHolding(s) in Company
3rd Oct 20223:15 pmRNSTotal Voting Rights
15th Sep 202212:00 pmRNSDirector/PDMR Shareholding
14th Sep 202211:55 amRNSHolding(s) in Company
7th Sep 202211:00 amRNSHolding(s) in Company
1st Sep 202211:00 amRNSTotal Voting Rights
12th Aug 20223:30 pmRNSHolding(s) in Company
11th Aug 20223:30 pmRNSDirector/PDMR Shareholding
10th Aug 20224:45 pmRNSHolding(s) in Company
2nd Aug 20227:00 amRNS2022 Half Year Results
1st Aug 202211:00 amRNSTotal Voting Rights
18th Jul 20223:00 pmRNSHolding(s) in Company
15th Jul 20229:22 amRNSHolding(s) in Company
12th Jul 20225:22 pmRNSDirector/PDMR Shareholding
1st Jul 202212:00 pmRNSTotal Voting Rights
20th Jun 202210:30 amRNSPublication of 2021 Sustainability Report
6th Jun 20225:15 pmRNSDirector/PDMR Shareholding
1st Jun 202212:00 pmRNSTotal Voting Rights
30th May 202212:30 pmRNSDirector/PDMR Shareholding
17th May 20224:30 pmRNSHolding(s) in Company
17th May 20223:30 pmRNSDirector/PDMR Shareholding
12th May 202210:30 amRNSDirector/PDMR Shareholding
5th May 20223:30 pmRNSDirector/PDMR Shareholding
4th May 202210:15 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.